一、Technology：Integrating plant extract A, probiotic B and compound C as a synbiotic to prevent and treat obesity-related diseases

二、Provider：Prof. Cheng-Chih Hsu /Department of Chemistry, National Taiwan U.

三、Enterprise Eligibility： 

1. Industry Category：Medical biotechnology

2. Required Technical Know-how：Research and development capabilities of next-generation probiotics and microbial treatment

3. Required Machinery and Equipment：High resolution mass spectrometer, analytical platform  for  metabolome analysis, isolation and culture platform of anaerobic bacteria

4. Required Research or Technical Staff：Researchers with a Ph.D. with expertise in the human microbiome, biochemistry, food science, nutrition science, biotechnology, or pharmacology

5. Other Requirements：No specific restrictions

The university's regulations relevant to technology transfer shall be complied with for matters not aforementioned.

四、How to apply？：Please go to the Center of Industrial-Academic Cooperation of the Office of Research and Development to inquire about relevant information.

五、Announcement deadline：112/6/30

Intellectual Property & Licensing Manager：Lanie Chen

TEL：02-33669952

Email：laniechen@ntu.edu.tw